We found that the mRNA expression of TSC22D3 gene encoding for GILZ in humans was significantly lower in NASH patients with a fat score ≥70 compared to the healthy control and healthy obese patients group (Fig. 7A). Here, TSC22D3 is linked to metabolic dysfunction-associated steatohepatitis.